Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 418.
Article
Abdelnour, C;
van Steenoven, I;
Londos, E;
Blanc, F;
Auestad, B;
Kramberger, MG;
Zetterberg, H;
... Aarsland, D; + view all
(2019)
Correction: Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
[Corrigendum].
Movement Disorders
, 34
(4)
p. 593.
10.1002/mds.27672.
|
Allison, SL;
Koscik, RL;
Cary, RP;
Jonaitis, EM;
Rowley, HA;
Chin, NA;
Zetterberg, H;
... Johnson, SC; + view all
(2019)
Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
NeuroImage: Clinical
, 23
, Article 101895. 10.1016/j.nicl.2019.101895.
|
Altomare, D;
Ferrari, C;
Caroli, A;
Galluzzi, S;
Prestia, A;
van der Flier, WM;
Ossenkoppele, R;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2019)
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
Journal of Neurology
, 266
pp. 2535-2545.
10.1007/s00415-019-09441-7.
|
Anderson, D;
Ferreira-Correia, A;
Brogueira Rodrigues, F;
Aziz, A;
Carr, J;
Wild, E;
Margolis, R;
(2019)
Comparison of the Huntington’s disease-like 2 and Huntington’s disease clinical phenotypes.
Movement Disorders Clinical Practice
(In press).
|
Andersson, A;
Remnestål, J;
Nellgård, B;
Vunk, H;
Kotol, D;
Edfors, F;
Uhlén, M;
... Fredolini, C; + view all
(2019)
Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease.
Clinica Chimica Acta
, 494
pp. 79-93.
10.1016/j.cca.2019.03.243.
|
Arber, C;
Villegas-Llerena, C;
Toombs, J;
Pocock, JM;
Ryan, NS;
Fox, NC;
Zetterberg, H;
... Wray, S; + view all
(2019)
Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout.
Brain Communications
10.1093/braincomms/fcz024.
(In press).
|
Arboleda-Velasquez, JF;
Lopera, F;
O'Hare, M;
Delgado-Tirado, S;
Marino, C;
Chmielewska, N;
Saez-Torres, KL;
... Quiroz, YT; + view all
(2019)
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
Nature Medicine
, 25
(11)
pp. 1680-1683.
10.1038/s41591-019-0611-3.
|
Ashton, NJ;
Ide, M;
Zetterberg, H;
Blennow, K;
(2019)
Salivary Biomarkers for Alzheimer's Disease and Related Disorders.
Neurology and Therapy
, 8
(S2)
pp. 83-94.
10.1007/s40120-019-00168-1.
|
Ashton, NJ;
Leuzy, A;
Lim, YM;
Troakes, C;
Hortobagyi, T;
Hoglund, K;
Aarsland, D;
... Hye, A; + view all
(2019)
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
Acta Neuropathologica Communications
, 7
, Article 5. 10.1186/s40478-018-0649-3.
|
Ashton, NJ;
Nevado-Holgado, AJ;
Barber, IS;
Lynham, S;
Gupta, V;
Chatterjee, P;
Goozee, K;
... Hye, A; + view all
(2019)
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Science Advances
, 5
(2)
, Article eaau7220. 10.1126/sciadv.aau7220.
|
Ashton, NJ;
Suárez-Calvet, M;
Heslegrave, A;
Hye, A;
Razquin, C;
Pastor, P;
Sanchez-Valle, R;
... Zetterberg, H; + view all
(2019)
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers.
Alzheimer's Research & Therapy
, 11
, Article 94. 10.1186/s13195-019-0545-5.
|
Babulal, GM;
Quiroz, YT;
Albensi, BC;
Arenaza-Urquijo, E;
Astell, AJ;
Babiloni, C;
Bahar-Fuchs, A;
... International Society to Advance Alzheimer's Research and Treatm, .; + view all
(2019)
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Alzheimer's and Dementia
, 15
(2)
pp. 292-312.
10.1016/j.jalz.2018.09.009.
|
Baker, E;
Sims, R;
Leonenko, G;
Frizzati, A;
Harwood, JC;
Grozeva, D;
GERAD/PERADES, .;
... Escott-Price, V; + view all
(2019)
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
PLoS One
, 14
(7)
, Article e0218111. 10.1371/journal.pone.0218111.
|
Balendra, R;
Al Khleifat, A;
Fang, T;
Al-Chalabi, A;
(2019)
A standard operating procedure for King's ALS clinical staging.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
, 20
(3-4)
pp. 159-164.
10.1080/21678421.2018.1556696.
|
Bandres-Ciga, S;
Ahmed, S;
Sabir, MS;
Blauwendraat, C;
Adarmes-Gomez, AD;
Bernal-Bernal, I;
Bonilla-Toribio, M;
... Singleton, A; + view all
(2019)
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.
Movement Disorders
10.1002/mds.27864.
(In press).
|
Bandres-Ciga, S;
Noyce, AJ;
Hemani, G;
Nicolas, A;
Calvo, A;
Mora, G;
Tienari, PJ;
... Traynor, BJ; + view all
(2019)
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.
Annals of Neurology
, 85
(4)
pp. 470-481.
10.1002/ana.25431.
|
Bandres-Ciga, S;
Saez-Atienzar, S;
Bonet-Ponce, L;
Billingsley, K;
Vitale, D;
Blauwendraat, C;
Gibbs, JR;
... Singleton, AB; + view all
(2019)
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease.
Movement Disorders
, 34
(4)
pp. 460-468.
10.1002/mds.27614.
|
Banerjee, G;
Adams, ME;
Jaunmuktane, Z;
Lammie, GA;
Turner, B;
Wani, M;
Sawhney, IMS;
... Werring, DJ; + view all
(2019)
Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura.
Annals of Neurology
, 85
(2)
pp. 284-290.
10.1002/ana.25407.
|
Bateman, R;
Blennow, K;
Doody, R;
Hendrix, S;
Lovestone, S;
Salloway, S;
Schindler, R;
... Zetterberg, H; + view all
(2019)
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report.
The Journal of Prevention of Alzheimer's Disease
, 6
(3)
pp. 169-173.
10.14283/jpad.2019.21.
|
Bendlin, BB;
Zetterberg, H;
(2019)
Screening with a high precision blood-based assay for Alzheimer disease.
[Editorial comment].
Neurology
10.1212/WNL.0000000000008080.
(In press).
|
Benedet, AL;
Ashton, NJ;
Pascoal, TA;
Leuzy, A;
Mathotaarachchi, S;
Kang, MS;
Therriault, J;
... Neto, PR; + view all
(2019)
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 679-689.
10.1016/j.dadm.2019.08.002.
|
Bernick, C;
Shan, G;
Zetterberg, H;
Banks, S;
Mishra, VR;
Bekris, L;
Leverenz, JB;
(2019)
Longitudinal change in regional brain volumes with exposure to repetitive head impacts.
Neurology
10.1212/WNL.0000000000008817.
(In press).
|
Bhattacharjee, P;
Öhrfelt, A;
Lashley, T;
Blennow, K;
Brinkmalm, A;
Zetterberg, H;
(2019)
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.
Journal of Proteome Research
, 18
(5)
pp. 2109-2120.
10.1021/acs.jproteome.8b00982.
|
Bhome, R;
Huntley, JD;
Price, G;
Howard, RJ;
(2019)
Clinical presentation and neuropsychological profiles of Functional Cognitive Disorder patients with and without co-morbid depression.
Cognitive Neuropsychiatry
, 24
(2)
pp. 152-164.
10.1080/13546805.2019.1590190.
|
Bhome, R;
McWilliams, A;
Huntley, JD;
Fleming, SM;
Howard, RJ;
(2019)
Metacognition in functional cognitive disorder- a potential mechanism and treatment target.
Cognitive Neuropsychiatry
, 24
(5)
pp. 311-321.
10.1080/13546805.2019.1651708.
|
Billingsley, KJ;
Barbosa, IA;
Bandrés-Ciga, S;
Quinn, JP;
Bubb, VJ;
Deshpande, C;
Botia, JA;
... Koks, S; + view all
(2019)
Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset.
npj Parkinson's Disease
, 5
, Article 8. 10.1038/s41531-019-0080-x.
|
Blauwendraat, C;
Heilbron, K;
Vallerga, CL;
Bandres-Ciga, S;
von Coelln, R;
Pihlstrøm, L;
Simón-Sánchez, J;
... International Parkinson's Disease Genomics Consortium (IPDGC); + view all
(2019)
Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.
Movement Disorders
10.1002/mds.27659.
(In press).
|
Blennow, K;
Diaz-Lucena, D;
Zetterberg, H;
Villar-Pique, A;
Karch, A;
Vidal, E;
Hermann, P;
... Llorens, F; + view all
(2019)
CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2018-320155.
(In press).
|
Bocchetta, M;
Iglesias, JE;
Cash, DM;
Warren, JD;
Rohrer, JD;
(2019)
Amygdala subnuclei are differentially affected in the different genetic and pathological forms of frontotemporal dementia.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 136-141.
10.1016/j.dadm.2018.12.006.
(In press).
|
Bocchetta, M;
Iglesias, JE;
Russell, L;
Greaves, CV;
Marshall, C;
Scelsi, MA;
Cash, D;
... Rohrer, J; + view all
(2019)
Segmentation of medial temporal subregions reveals early right-sided involvement in semantic variant PPA.
Alzheimer's Research and Therapy
, 11
, Article 41. 10.1186/s13195-019-0489-9.
|
Bonham, LW;
Steele, NZR;
Karch, CM;
Broce, I;
Geier, EG;
Wen, NL;
Momeni, P;
... International FTD-Genomics Consortium (IFGC), .; + view all
(2019)
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.
Scientific Reports
, 9
, Article 10854. 10.1038/s41598-019-46415-1.
|
Bonvicini, C;
Scassellati, C;
Benussi, L;
Di Maria, E;
Maj, C;
Ciani, M;
Fostinelli, S;
... Gennarelli, M; + view all
(2019)
Next Generation Sequencing Analysis in Early Onset Dementia Patients.
Journal of Alzheimer's Disease
, 67
(1)
pp. 243-256.
10.3233/JAD-180482.
|
Bos, I;
Vos, S;
Verhey, F;
Scheltens, P;
Teunissen, C;
Engelborghs, S;
Sleegers, K;
... Visser, PJ; + view all
(2019)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimer's & Dementia
, 15
(5)
pp. 644-654.
10.1016/j.jalz.2019.01.004.
|
Bowen, M;
Zutshi, H;
Cordiner, M;
Crutch, S;
Shakespeare, T;
(2019)
Qualitative, exploratory pilot study to investigate how people living with posterior cortical atrophy, their carers and clinicians experience tests used to assess vision.
BMJ Open
, 9
(3)
, Article e020905. 10.1136/bmjopen-2017-020905.
|
Brandner, S;
Jaunmuktane, Z;
(2019)
IDH mutant astrocytoma: biomarkers for prognostic stratification and the next frontiers.
[Editorial comment].
Neuropathology and Applied Neurobiology
, 45
(2)
pp. 91-94.
10.1111/nan.12521.
|
Bridel, C;
van Wieringen, WN;
Zetterberg, H;
Tijms, BM;
Teunissen, CE;
and the NFL Group;
Alvarez-Cermeño, JC;
... Wild, EJ; + view all
(2019)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
JAMA Neurology
10.1001/jamaneurol.2019.1534.
(In press).
|
Brinkmalm, A;
Portelius, E;
Brinkmalm, G;
Pannee, J;
Dahlén, R;
Gobom, J;
Blennow, K;
(2019)
Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases.
Journal of Neurochemistry
, 151
(4)
pp. 417-434.
10.1111/jnc.14594.
|
Brinkmalm, G;
Hong, W;
Wang, Z;
Liu, W;
O'Malley, TT;
Sun, X;
Frosch, MP;
... Walsh, DM; + view all
(2019)
Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain.
Brain
, 142
(5)
pp. 1441-1457.
10.1093/brain/awz066.
|
Brogueira Rodrigues, F;
Ferreira, JJ;
Wild, EJ;
(2019)
Huntington’s Disease Clinical Trials Corner: June 2019.
Journal of Huntington's disease
, 8
(3)
pp. 363-371.
10.3233/JHD-199003.
|
Brogueira Rodrigues, F;
Quinn, L;
Wild, E;
(2019)
Huntington's Disease Clinical Trials Corner: January 2019.
Journal of Huntington's Disease
, 8
(1)
pp. 115-125.
10.3233/JHD-190001.
|
Brogueira Rodrigues, FA;
Byrne, L;
De Vita, E;
Johnson, E;
Hobbs, N;
Thornton, J;
Scahill, R;
(2019)
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.
European Journal of Neuroscience
10.1111/ejn.14356.
(In press).
|
Bruno, D;
Gleason, CE;
Koscik, RL;
Pomara, N;
Zetterberg, H;
Blennow, K;
Johnson, SC;
(2019)
The recency ratio is related to CSF amyloid beta 1‐42 levels in MCI‐AD.
International Journal of Geriatric Psychiatry
, 34
(3)
pp. 415-419.
10.1002/gps.5029.
|
Bugiardini, E;
Pope, S;
Feichtinger, RG;
Poole, OV;
Pittman, AM;
Woodward, CE;
Heales, S;
... Pitceathly, RDS; + view all
(2019)
Utility of Whole Blood Thiamine Pyrophosphate Evaluation in TPK1-Related Diseases.
Journal Of Clinical Medicine
, 8
(7)
, Article 991. 10.3390/jcm8070991.
|
Cali, CP;
Patino, M;
Tai, YK;
Ho, WY;
McLean, CA;
Morris, CM;
Seeley, WW;
... Lee, EB; + view all
(2019)
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.
Acta Neuropathologica
, 138
(5)
pp. 795-811.
10.1007/s00401-019-02045-5.
|
Canas, LS;
Sudre, CH;
De Vita, E;
Nihat, A;
Mok, TH;
Slattery, CF;
Paterson, RW;
... Modat, M; + view all
(2019)
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.
NeuroImage: Clinical
, Article 102051. 10.1016/j.nicl.2019.102051.
(In press).
|
Chatterjee, P;
Elmi, M;
Goozee, K;
Shah, T;
Sohrabi, HR;
Dias, CB;
Pedrini, S;
... Martins, RN; + view all
(2019)
Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
Journal of Alzheimer's Disease
, 71
(3)
pp. 775-783.
10.3233/JAD-190533.
|
Chatterjee, P;
Zetterberg, H;
Goozee, K;
Lim, CK;
Jacobs, KR;
Ashton, NJ;
Hye, A;
... Martins, RN; + view all
(2019)
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Journal of Neuroinflammation
, 16
, Article 2019. 10.1186/s12974-019-1567-4.
|
Chaudhury, S;
Brookes, KJ;
Patel, T;
Fallows, A;
Guetta-Baranes, T;
Turton, JC;
Guerreiro, R;
... Thomas, AJ; + view all
(2019)
Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.
Translational Psychiatry
, 9
, Article 154. 10.1038/s41398-019-0485-7.
|
Chelban, V;
Bocchetta, M;
Hassanein, S;
Haridy, NA;
Houlden, H;
Rohrer, JD;
(2019)
An update on advances in magnetic resonance imaging of multiple system atrophy.
Journal of Neurology
, 266
(4)
pp. 1036-1045.
10.1007/s00415-018-9121-3.
|
Chelban, V;
Wilson, MP;
Warman Chardon, J;
Vandrovcova, J;
Zanetti, MN;
Zamba-Papanicolaou, E;
Efthymiou, S;
... SYNaPS Study Group, .; + view all
(2019)
PDXK mutations cause polyneuropathy responsive to PLP supplementation.
Annals of Neurology
10.1002/ana.25524.
(In press).
|
Chen, Z;
et al, .;
(2019)
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Movement Disorders
10.1002/mds.27702..
(In press).
|
Chen, Z;
Houlden, H;
Puzriakova, A;
(2019)
Spinocerebellar Ataxia Type 11.
GeneReviews
(In press).
|
Chen, Z;
Mengel, D;
Keshavan, A;
Rissman, RA;
Billinton, A;
Perkinton, M;
Percival-Alwyn, J;
... Walsh, DM; + view all
(2019)
Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
Alzheimer's & Dementia
, 15
(3)
pp. 487-496.
10.1016/j.jalz.2018.09.010.
|
Cheng, SF;
Zarkali, A;
Richards, T;
Simister, R;
Chandratheva, A;
(2019)
Carotid artery stenosis, an underestimated cause of stroke recurrence in patients with ischaemic monocular visual loss.
Annals of the Royal College of Surgeons of England
, 101
(8)
pp. 579-583.
10.1308/rcsann.2019.0071.
|
Chew, B;
Hauser, TU;
Papoutsi, M;
Magerkurth, J;
Dolan, RJ;
Rutledge, RB;
(2019)
Endogenous fluctuations in the dopaminergic midbrain drive behavioral choice variability.
Proceedings of the National Academy of Sciences (PNAS)
10.1073/pnas.1900872116.
(In press).
|
Christopher, E;
Poon, MTC;
Glancz, LJ;
Hutchinson, PJ;
Kolias, AG;
Brennan, PM;
Afshari, FT;
... Zaben, M; + view all
(2019)
Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma.
Neurosurgical Review
, 42
(2)
427`-431.
10.1007/s10143-018-0979-4.
|
Cicognola, C;
Brinkmalm, G;
Wahlgren, J;
Portelius, E;
Gobom, J;
Cullen, NC;
Hansson, O;
... Höglund, K; + view all
(2019)
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
Acta Neuropathologica
10.1007/s00401-018-1948-2.
(In press).
|
Ciosi, M;
Maxwell, A;
Cumming, SA;
Hensman Moss, DJ;
Alshammari, AM;
Flower, MD;
Durr, A;
... Monckton, DG; + view all
(2019)
A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
EBioMedicine
10.1016/j.ebiom.2019.09.020.
(In press).
|
Clare, A;
Camic, PM;
Crutch, SJ;
West, J;
Harding, E;
Brotherhood, E;
(2019)
Using Music to Develop a Multisensory Communicative Environment for People with Late-Stage Dementia.
The Gerontologist
10.1093/geront/gnz169.
(In press).
|
Clarke, MTM;
Brinkmalm, A;
Foiani, MS;
Woollacott, IOC;
Heller, C;
Heslegrave, A;
Keshavan, A;
... Rohrer, JD; + view all
(2019)
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia.
Alzheimer's Research and Therapy
, 11
, Article 105. 10.1186/s13195-019-0564-2.
|
Cohen, AD;
Landau, SM;
Snitz, BE;
Klunk, WE;
Blennow, K;
Zetterberg, H;
(2019)
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
Molecular and Cellular Neuroscience
, 97
pp. 3-17.
10.1016/j.mcn.2018.12.004.
|
Convery, R;
Mead, S;
Rohrer, JD;
(2019)
Review: Clinical, genetic and neuroimaging features of frontotemporal dementia.
Neuropathology and Applied Neurobiology
, 45
(1)
pp. 6-18.
10.1111/nan.12535.
|
Convery, RS;
Jiao, J;
Clarke, MTM;
Moore, KM;
Koriath, CAM;
Woollacott, IOC;
Weston, PSJ;
... Rohrer, JD; + view all
(2019)
Longitudinal (¹⁸F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320904.
(In press).
|
Craven, CL;
Chapman, MD;
D'Antona, L;
Thompson, SD;
Lakdawala, N;
Zetterberg, H;
Watkins, LD;
(2019)
Lumbar drains can affect CSF biomarker levels.
[Letter].
Journal of Clinical Pathology
, 72
(1)
pp. 91-92.
10.1136/jclinpath-2018-205296.
|
Cunningham, EL;
McGuinness, B;
McAuley, DF;
Toombs, J;
Mawhinney, T;
O'Brien, S;
Beverland, D;
... Passmore, AP; + view all
(2019)
CSF Beta-amyloid 1-42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort Study.
Annals of Surgery
, 269
(6)
pp. 1200-1205.
10.1097/SLA.0000000000002684.
|
Cury, C;
Durrleman, S;
Cash, DM;
Lorenzi, M;
Nicholas, JM;
Bocchetta, M;
van Swieten, JC;
... Genetic FTD Initiative, GENFI, .; + view all
(2019)
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort.
Neuroimage
, 188
pp. 282-290.
10.1016/j.neuroimage.2018.11.063.
|
De, S;
Whiten, DR;
Ruggeri, FS;
Hughes, C;
Rodrigues, M;
Sideris, D;
Taylor, CG;
... Klenerman, D; + view all
(2019)
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.
Acta Neuropathologica Communications
, 7
, Article 120. 10.1186/s40478-019-0777-4.
|
de Flon, P;
Laurell, K;
Sundström, P;
Blennow, K;
Söderström, L;
Zetterberg, H;
Gunnarsson, M;
(2019)
Comparison of plasma and CSF Neurofilament-light in an MS trial.
Acta Neurologica Scandinavica
, 139
(5)
pp. 462-468.
10.1111/ane.13078.
|
De Francesco, D;
Choi, J-P;
Choi, JY;
van Zoest, RA;
Underwood, J;
Schouten, J;
Ku, NS;
... van Zoest, RA; + view all
(2019)
Cognitive function and drivers of cognitive impairment in a European and a Korean cohort of people living with HIV.
International Journal of STD & AIDS
10.1177/0956462419881080.
(In press).
|
De Francesco, D;
Wit, FW;
Bürkle, A;
Oehlke, S;
Kootstra, NA;
Winston, A;
Franceschi, C;
... The Co-morBidity in Relation to AIDS (COBRA) Collaboration, .; + view all
(2019)
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
AIDS
, 33
(2)
pp. 259-268.
10.1097/QAD.0000000000002063.
|
Deisenhammer, F;
Zetterberg, H;
Fitzner, B;
Zettl, UK;
(2019)
The Cerebrospinal Fluid in Multiple Sclerosis.
[Review].
Frontiers in Immunology
, 10
, Article 726. 10.3389/fimmu.2019.00726.
|
Delsing, L;
Kallur, T;
Zetterberg, H;
Hicks, R;
Synnergren, J;
(2019)
Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.
Fluids and Barriers of the CNS
, 16
, Article 27. 10.1186/s12987-019-0147-4.
|
DeMarshall, C;
Oh, E;
Kheirkhah, R;
Sieber, F;
Zetterberg, H;
Blennow, K;
Nagele, RG;
(2019)
Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
PLoS One
, 14
(11)
, Article e0225178. 10.1371/journal.pone.0225178.
|
Deming, Y;
Filipello, F;
Cignarella, F;
Cantoni, C;
Hsu, S;
Mikesell, R;
Li, Z;
... Cruchaga, C; + view all
(2019)
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.
Science Translational Medicine
, 11
(505)
, Article eaau2291. 10.1126/scitranslmed.aau2291.
|
den Haan, J;
Csinscik, L;
Parker, T;
Paterson, RW;
Slattery, CF;
Foulkes, A;
Bouwman, FH;
... Yong, KXX; + view all
(2019)
Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.
Alzheimer's Research and Therapy
, 11
, Article 62. 10.1186/s13195-019-0516-x.
|
Desmarais, P;
Rohrer, JD;
Nguyen, QD;
Herrmann, N;
Stuss, DT;
Lang, AE;
Boxer, AL;
... Masellis, M; + view all
(2019)
Therapeutic trial design for frontotemporal dementia and related disorders.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-318603.
(In press).
|
Dhiman, K;
Blennow, K;
Zetterberg, H;
Martins, RN;
Gupta, VB;
(2019)
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis.
Cellular and Molecular Life Sciences
, 76
pp. 1833-1863.
10.1007/s00018-019-03040-5.
|
Duarte, GS;
Nunes-Ferreira, A;
Brogueira Rodrigues, F;
Pinto, F;
Ferreira, JJ;
Costa, J;
Caldeira, D;
(2019)
Morphine in acute coronary syndrome: systematic review and meta-analysis.
BMJ Open
, 9
(3)
, Article e025232. 10.1136/bmjopen-2018-025232.
|
Dube, U;
Del-Aguila, JL;
Li, Z;
Budde, JP;
Jiang, S;
Hsu, S;
Ibanez, L;
... Xu, X; + view all
(2019)
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
Nature Neuroscience
, 22
pp. 1903-1912.
10.1038/s41593-019-0501-5.
|
Dumitrescu, L;
Barnes, LL;
Thambisetty, M;
Beecham, G;
Kunkle, B;
Bush, WS;
Gifford, KA;
... Hohman, TJ; + view all
(2019)
Sex differences in the genetic predictors of Alzheimer's pathology.
Brain
, 142
(9)
pp. 2581-2589.
10.1093/brain/awz206.
|
Efthymiou, S;
Salpietro, V;
Malintan, N;
Poncelet, M;
Kriouile, Y;
Fortuna, S;
De Zorzi, R;
... Houlden, H; + view all
(2019)
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination.
Brain
10.1093/brain/awz248.
(In press).
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
Correction: The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(2)
, Article e0212830. 10.1371/journal.pone.0212830.
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(1)
, Article e0211184. 10.1371/journal.pone.0211184.
|
Erickson, CM;
Schultz, SA;
Oh, JM;
Darst, BF;
Ma, Y;
Norton, D;
Betthauser, T;
... Okonkwo, OC; + view all
(2019)
KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD.
Neurology
10.1212/WNL.0000000000007323.
(In press).
|
Escott-Price, V;
Baker, E;
Shoai, M;
Leonenko, G;
Myers, AJ;
Huentelman, M;
Hardy, J;
(2019)
Genetic analysis suggests high misassignment rates in clinical Alzheimer's cases and controls.
Neurobiology of Aging
, 77
pp. 178-182.
10.1016/j.neurobiolaging.2018.12.002.
|
Escott-Price, V;
Myers, A;
Huentelman, M;
Shoai, M;
Hardy, J;
(2019)
Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles.
The Journal of Prevention of Alzheimer’s Disease
, 6
(1)
pp. 16-19.
10.14283/jpad.2018.46.
|
Femminella, GD;
Frangou, E;
Love, SB;
Busza, G;
Holmes, C;
Ritchie, C;
Lawrence, R;
... Edison, P; + view all
(2019)
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Trials
, 20
, Article 191. 10.1186/s13063-019-3259-x.
|
Firth, NC;
Primativo, S;
Marinescu, R-V;
Shakespeare, TJ;
Suarez-Gonzalez, A;
Lehmann, M;
Carton, A;
... Crutch, SJ; + view all
(2019)
Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy.
Brain
, 142
(7)
pp. 2082-2095.
10.1093/brain/awz136.
|
Fisher, CK;
Smith, AM;
Walsh, JR;
Simone, AJ;
Edgar, C;
Jack, CR;
Holtzman, D;
... Kubick, W; + view all
(2019)
Machine learning for comprehensive forecasting of Alzheimer's Disease progression.
Scientific Reports
, 9
, Article 13622. 10.1038/s41598-019-49656-2.
|
Flower, M;
Lomeikaite, V;
Ciosi, M;
Cumming, S;
Morales, F;
Lo, K;
Hensman Moss, D;
... Tabrizi, SJ; + view all
(2019)
MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.
Brain
, 142
(7)
pp. 1876-1886.
10.1093/brain/awz115.
|
Foiani, MS;
Cicognola, C;
Ermann, N;
Woollacott, IOC;
Heller, C;
Heslegrave, AJ;
Keshavan, A;
... Rohrer, JD; + view all
(2019)
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-319266.
(In press).
|
Forsberg, M;
Seth, H;
Björefeldt, A;
Lyckenvik, T;
Andersson, M;
Wasling, P;
Zetterberg, H;
(2019)
Ionized calcium in human cerebrospinal fluid and its influence on intrinsic and synaptic excitability of hippocampal pyramidal neurons in the rat.
Journal of Neurochemistry
, 149
(4)
pp. 452-470.
10.1111/jnc.14693.
|
Fossati, S;
Ramos Cejudo, J;
Debure, L;
Pirraglia, E;
Sone, JY;
Li, Y;
Chen, J;
... de Leon, MJ; + view all
(2019)
Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 483-492.
10.1016/j.dadm.2019.05.001.
(In press).
|
Foti, S;
Hargreaves, I;
Carrington, S;
Kiely, AP;
Houlden, H;
Holton, J;
(2019)
Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease.
Scientific Reports
, 9
, Article 6559. 10.1038/s41598-019-42902-7.
|
Frankel, R;
Törnquist, M;
Meisl, G;
Hansson, O;
Andreasson, U;
Zetterberg, H;
Blennow, K;
... Linse, S; + view all
(2019)
Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid.
Communications Biology
, 2
, Article 365. 10.1038/s42003-019-0612-2.
|
Frisoni, GB;
Barkhof, F;
Altomare, D;
Berkhof, J;
Boccardi, M;
Canzoneri, E;
Collij, L;
... Raffa, N; + view all
(2019)
AMYPAD Diagnostic and Patient Management Study: Rationale and Design.
Alzheimer's & Dementia
, 15
(3)
pp. 388-399.
10.1016/j.jalz.2018.09.003.
|
Gaetani, L;
Blennow, K;
Calabresi, P;
Di Filippo, M;
Parnetti, L;
Zetterberg, H;
(2019)
Neurofilament light chain as a biomarker in neurological disorders.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(8)
pp. 870-881.
10.1136/jnnp-2018-320106.
|
Gaetani, L;
Eusebi, P;
Mancini, A;
Gentili, L;
Borrelli, A;
Parnetti, L;
Calabresi, P;
... Di Filippo, M; + view all
(2019)
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
Multiple Sclerosis and Related Disorders
, 35
pp. 228-232.
10.1016/j.msard.2019.07.025.
|
Gaetani, L;
Salvadori, N;
Lisetti, V;
Eusebi, P;
Mancini, A;
Gentili, L;
Borrelli, A;
... Di Filippo, M; + view all
(2019)
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
Journal of Neurology
, 266
pp. 2157-2163.
10.1007/s00415-019-09398-7.
|
Gafson, AR;
Savva, C;
Thorne, T;
David, M;
Gomez-Romero, M;
Lewis, MR;
Nicholas, R;
... Matthews, PM; + view all
(2019)
Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate.
Neurology: Neuroimmunology & NeuroInflammation
, 6
(3)
, Article e562. 10.1212/NXI.0000000000000562.
|
Garbarino, S;
Lorenzi, M;
Oxtoby, NP;
Vinke, EJ;
Marinescu, RV;
Eshaghi, A;
Ikram, MA;
... Alexander, DC; + view all
(2019)
Differences in topological progression profile among neurodegenerative diseases from imaging data.
eLife
, 8
10.7554/eLife.49298.
(In press).
|
Gatenholm, B;
Gobom, J;
Skillbäck, T;
Blennow, K;
Zetterberg, H;
Brittberg, M;
(2019)
Peptidomic Analysis of Cartilage and Subchondral bone in OA patients.
European Journal of Clinical Investigation
, 49
(5)
, Article e13082. 10.1111/eci.13082.
|
Gazzina, S;
Grassi, M;
Premi, E;
Cosseddu, M;
Alberici, A;
Archetti, S;
Gasparotti, R;
... Genetic FTD Initiative, GENFI, .; + view all
(2019)
Education modulates brain maintenance in presymptomatic frontotemporal dementia.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2019-320439.
(In press).
|
Ghasemi, DR;
Sill, M;
Okonechnikov, K;
Korshunov, A;
Yip, S;
Schutz, PW;
Scheie, D;
... Pajtler, KW; + view all
(2019)
MYCN amplification drives an aggressive form of spinal ependymoma.
Acta Neuropathologica
, 138
pp. 1075-1089.
10.1007/s00401-019-02056-2.
|
Gisslen, M;
Heslegrave, A;
Veleva, E;
Yilmaz, A;
Andersson, L-M;
Hagberg, L;
Spudich, S;
... Zetterberg, H; + view all
(2019)
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
Neurology, Neuroimmunology and Neuroinflammation
, 6
(1)
, Article e512. 10.1212/NXI.0000000000000512.
|
Gittings, LM;
Boeynaems, S;
Lightwood, D;
Clargo, A;
Topia, S;
Nakayama, L;
Troakes, C;
... Isaacs, AM; + view all
(2019)
Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity.
Acta Neuropathologica
10.1007/s00401-019-02104-x.
(In press).
|
Gittings, LM;
Foti, SC;
Benson, BC;
Gami-Patel, P;
Isaacs, AM;
Lashley, T;
(2019)
Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
Acta Neuropathol Commun
, 7
(1)
, Article 18. 10.1186/s40478-019-0673-y.
|
Gkanatsiou, E;
Portelius, E;
Toomey, CE;
Blennow, K;
Zetterberg, H;
Lashley, T;
Brinkmalm, G;
(2019)
A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Neuroscience Letters
, 701
pp. 125-131.
10.1016/j.neulet.2019.02.033.
|
González, AS;
Hoffman, P;
Crutch, S;
(2019)
Where words meet numbers: Comprehension of measurement unit terms in posterior cortical atrophy.
Neuropsychologia
, 131
pp. 216-222.
10.1016/j.neuropsychologia.2019.05.004.
|
Gorgoraptis, N;
Li, LM;
Whittington, A;
Zimmerman, KA;
Maclean, LM;
McLeod, C;
Ross, E;
... Sharp, DJ; + view all
(2019)
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury.
Science Translational Medicine
, 11
(508)
, Article eaaw1993. 10.1126/scitranslmed.aaw1993.
|
Grand, J;
Kjaergaard, J;
Nielsen, N;
Friberg, H;
Cronberg, T;
Bro-Jeppesen, J;
Karsdal, MA;
... Hassager, C; + view all
(2019)
Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest.
Biomarkers
, 24
(6)
pp. 584-591.
10.1080/1354750X.2019.1609580.
|
Greaves, CV;
Rohrer, JD;
(2019)
An update on genetic frontotemporal dementia.
Journal of Neurology
, 266
(8)
pp. 2075-2086.
10.1007/s00415-019-09363-4.
|
Gregory, S;
Odish, OFF;
Mayer, I;
Mills, J;
Johnson, EB;
Scahill, RI;
Rothwell, J;
... Orth, M; + view all
(2019)
Multimodal characterization of the visual network in Huntington's disease gene carriers.
Clinical Neurophysiology
, 130
(11)
pp. 2053-2059.
10.1016/j.clinph.2019.08.018.
|
Guelfi, S;
Botia, JA;
Thom, M;
Ramasamy, A;
Perona, M;
Stanyer, L;
Martinian, L;
... Matarin, M; + view all
(2019)
Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy.
Brain
, 142
(6)
pp. 1616-1630.
10.1093/brain/awz074.
|
Guerreiro, R;
Escott-Price, V;
Hernandez, DG;
Kun-Rodrigues, C;
Ross, OA;
Orme, T;
Neto, JL;
... Bras, J; + view all
(2019)
Heritability and genetic variance of dementia with Lewy bodies.
Neurobiology of Disease
, 127
pp. 492-501.
10.1016/j.nbd.2019.04.004.
|
Guerreiro, R;
Orme, T;
Naj, AC;
Kuzma, AB;
Schellenberg, GD;
Bras, J;
(2019)
Is APOE ε4 required for Alzheimer's disease to develop in TREM2 p.R47H variant carriers?
[Letter].
Neuropathology and Applied Neurobiology
, 45
(2)
pp. 187-189.
10.1111/nan.12517.
|
Guven, G;
Bilgic, B;
Tufekcioglu, Z;
Erginel Unaltuna, N;
Hanagasi, H;
Gurvit, H;
Singleton, A;
... Lohmann, E; + view all
(2019)
Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia.
Journal of Alzheimer's Disease
, 67
(1)
pp. 159-167.
10.3233/JAD-180599.
|
Habib, A;
Okorokov, A;
Hill, M;
Bras, J;
Lee, M-C;
Li, S;
Gossage, S;
... Cox, J; + view all
(2019)
Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity.
British Journal of Anaesthesia
, 123
(2)
e249-e253.
10.1016/j.bja.2019.02.019.
|
Hall, S;
Janelidze, S;
Zetterberg, H;
Brix, B;
Mattsson, N;
Surova, Y;
Blennow, K;
(2019)
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders.
Movement Disorders
10.1002/mds.27950.
(In press).
|
Hansen, D;
Ling, H;
Lashley, T;
Holton, J;
Warner, T;
(2019)
Clinical, neuropathological and genetic features of Lewy body dementias.
Neuropathology and Applied Neurobiology
, 45
(7)
pp. 635-654.
10.1111/nan.12554.
|
Hansson, K;
Dahlen, R;
Hansson, O;
Pernevik, E;
Paterson, R;
Schott, JM;
Magdalinou, N;
... Gobom, J; + view all
(2019)
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease.
Clinical Mass Spectrometry
, 14
(Part B)
pp. 74-82.
10.1016/j.clinms.2019.07.002.
|
Hansson, O;
Lehmann, S;
Otto, M;
Zetterberg, H;
Lewczuk, P;
(2019)
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
Alzheimer's Research & Therapy
, 11
, Article 34. 10.1186/s13195-019-0485-0.
|
Hardy, CJD;
Frost, C;
Sivasathiaseelan, H;
Johnson, JCS;
Agustus, JL;
Bond, RL;
Benhamou, E;
... Warren, JD; + view all
(2019)
Findings of Impaired Hearing in Patients With Nonfluent/Agrammatic Variant Primary Progressive Aphasia.
JAMA Neurology
10.1001/jamaneurol.2018.4799.
(In press).
|
Hardy, CJD;
Johnson, JCS;
Warren, JD;
(2019)
Auditory symptoms in primary progressive aphasia: A commentary on Utianski et al. (2019).
Cortex
, 119
pp. 580-582.
10.1016/j.cortex.2019.03.023.
|
Hardy, J;
(2019)
Failures in Protein Clearance Partly Underlie Late Onset Neurodegenerative Diseases and Link Pathology to Genetic Risk.
Frontiers in Neuroscience
, 13
, Article 1304. 10.3389/fnins.2019.01304.
|
Hardy, J;
Escott-Price, V;
(2019)
Genes, pathways and risk prediction in Alzheimer's disease.
Human Molecular Genetics
, 28
(R2)
R235-R240.
10.1093/hmg/ddz163.
|
Harrison, IF;
Whitaker, R;
Bertelli, PM;
O'Callaghan, JM;
Csincsik, L;
Bocchetta, M;
Ma, D;
... Lengyel, I; + view all
(2019)
Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia.
Acta Neuropathologica Communications
, 7
, Article 4. 10.1186/s40478-018-0654-6.
|
Hasselgren, C;
Ekbrand, H;
Fässberg, MM;
Zettergren, A;
Zetterberg, H;
Blennow, K;
Skoog, I;
(2019)
APOE ε₄ and the long arm of social inequity: estimated effects of socio-economic status and sex on the timing of dementia onset.
Ageing & Society
, 39
(9)
pp. 1951-1975.
10.1017/S0144686X18000351.
|
Hedberg-Oldfors, C;
Abramsson, A;
Osborn, DPS;
Danielsson, O;
Fazlinezhad, A;
Nilipour, Y;
Hübbert, L;
... Jamshidi, Y; + view all
(2019)
Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24.
Human Molecular Genetics
, 28
(11)
pp. 1919-1929.
10.1093/hmg/ddz032.
|
Heinzel, S;
Berg, D;
Gasser, T;
Chen, H;
Yao, C;
Postuma, RB;
Adler, CH;
... Stern, M; + view all
(2019)
Update of the MDS research criteria for prodromal Parkinson's disease.
Movement Disorders
, 34
(10)
pp. 1464-1470.
10.1002/mds.27802.
|
Hepner, A;
Porter, J;
Hare, F;
Nasir, SS;
Zetterberg, H;
Blennow, K;
Martin, MG;
(2019)
Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas.
World Journal of Oncology
, 10
(4-5)
pp. 169-175.
10.14740/wjon1228.
|
Hermansson, L;
Yilmaz, A;
Axelsson, M;
Blennow, K;
Fuchs, D;
Hagberg, L;
Lycke, J;
... Gisslén, M; + view all
(2019)
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.
Journal of Neuroinflammation
, 16
, Article 16. 10.1186/s12974-019-1404-9.
|
Hermansson, L;
Yilmaz, A;
Price, RW;
Nilsson, S;
McCallister, S;
Makadzange, T;
Das, M;
... Gisslen, M; + view all
(2019)
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
PLOS ONE
, 14
(12)
, Article e0226276. 10.1371/journal.pone.0226276.
|
Hett, K;
Ta, V-T;
Catheline, G;
Tourdias, T;
Manjón, JV;
Coupé, P;
Alzheimer’s Disease Neuroimaging Initiative;
(2019)
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification.
Scientific Reports
, 9
, Article 13845. 10.1038/s41598-019-49970-9.
|
Heurling, K;
Ashton, NJ;
Leuzy, A;
Zimmer, ER;
Blennow, K;
Zetterberg, H;
Eriksson, J;
... Schöll, M; + view all
(2019)
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies.
Molecular and Cellular Neuroscience
10.1016/j.mcn.2019.02.001.
(In press).
|
Hithersay, R;
Startin, CM;
Hamburg, S;
Mok, KY;
Hardy, J;
Fisher, EMC;
Tybulewicz, VLJ;
... Strydom, A; + view all
(2019)
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.
JAMA Neurology
, 76
(2)
pp. 152-160.
10.1001/jamaneurol.2018.3616.
|
Höglund, K;
Schussler, N;
Kvartsberg, H;
Smailovic, U;
Brinkmalm, G;
Liman, V;
Becker, B;
... Blennow, K; + view all
(2019)
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration.
Neurobiology of Disease
, 134
, Article 104645. 10.1016/j.nbd.2019.104645.
|
Holmøy, T;
Røsjø, E;
Zetterberg, H;
Blennow, K;
Lindstrøm, JC;
Steffensen, LH;
Kampman, MT;
(2019)
Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
Acta Neurologica Scandinavica
, 139
(2)
pp. 172-176.
10.1111/ane.13037.
|
Horga, A;
Bugiardini, E;
Manole, A;
Bremner, F;
Jaunmuktane, Z;
Dankwa, L;
Rebelo, AP;
... Reilly, MM; + view all
(2019)
Autosomal dominant optic atrophy and cataract “plus” phenotype including axonal neuropathy.
Neurology: Genetics
, 5
(2)
, Article e322. 10.1212/NXG.0000000000000322.
|
Hossain, I;
Mohammadian, M;
Takala, RS;
Tenovuo, O;
Lagerstedt, L;
Ala-Seppälä, HM;
Frantzén, J;
... Posti, JP; + view all
(2019)
Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury.
Journal of Neurotrauma
, 36
(10)
pp. 1551-1560.
10.1089/neu.2018.5952.
|
Hou, Y;
Pinheiro, J;
Sahm, F;
Reuss, DE;
Schrimpf, D;
Stichel, D;
Casalini, B;
... Bertero, L; + view all
(2019)
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
Acta Neuropathologica
, 137
pp. 837-846.
10.1007/s00401-019-01969-2.
|
Hu, Y;
Li, M;
Lu, Q;
Weng, H;
Wang, J;
Zekavat, SM;
Yu, Z;
... Yu, L; + view all
(2019)
A statistical framework for cross-tissue transcriptome-wide association analysis.
Nature Genetics
, 51
(3)
pp. 568-576.
10.1038/s41588-019-0345-7.
|
Huentelman, M;
De Both, M;
Jepsen, W;
Piras, IS;
Talboom, JS;
Willeman, M;
Reiman, EM;
... Myers, AJ; + view all
(2019)
Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.
Scientific Reports
, 9
, Article 9640. 10.1038/s41598-019-45896-4.
|
Hughes, CD;
Choi, ML;
Ryten, M;
Hopkins, L;
Drews, A;
Botía, JA;
Iljina, M;
... Klenerman, D; + view all
(2019)
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
Acta Neuropathologica
, 137
(1)
pp. 103-120.
10.1007/s00401-018-1907-y.
|
Hyare, H;
Rice, L;
Thust, S;
Nachev, P;
Jha, A;
Milic, M;
Brandner, S;
(2019)
Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.
European Journal of Radiology
, 114
pp. 120-127.
10.1016/j.ejrad.2019.03.003.
|
Irvine, EE;
Katsouri, L;
Plattner, F;
Al-Qassab, H;
Al-Nackkash, R;
Bates, GP;
Withers, DJ;
(2019)
Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's disease.
Scientific Reports
, 9
, Article 16133. 10.1038/s41598-019-52391-3.
|
Iverson, GL;
Reddi, PJ;
Posti, JP;
Kotilainen, A-K;
Tenovuo, O;
Öhman, J;
Zetterberg, H;
... Luoto, TM; + view all
(2019)
Serum Neurofilament Light is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries.
Journal of Neurotrauma
, 36
(16)
pp. 2400-2406.
10.1089/neu.2018.6341.
|
Jabbari, E;
Holland, N;
Chelban, V;
Jones, PS;
Lamb, R;
Rawlinson, C;
Guo, T;
... Morris, HR; + view all
(2019)
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
JAMA Neurology
, 77
(3)
pp. 377-387.
10.1001/jamaneurol.2019.4347.
|
Jabbari, E;
Woodside, J;
Guo, T;
Magdalinou, NK;
Chelban, V;
Athauda, D;
Lees, AJ;
... Morris, HR; + view all
(2019)
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-320151.
|
Jabbari, E;
Woodside, J;
Tan, MMX;
Pavese, N;
Bandmann, O;
Ghosh, BCP;
Massey, LA;
... Morris, HR; + view all
(2019)
The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.
Movement Disorders
10.1002/mds.27786.
(In press).
|
Jacobs, KR;
Lim, CK;
Blennow, K;
Zetterberg, H;
Chatterjee, P;
Martins, RN;
Brew, BJ;
... Lovejoy, DB; + view all
(2019)
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau.
Neurobiology of Aging
, 80
pp. 11-20.
10.1016/j.neurobiolaging.2019.03.015.
|
Jadhav, S;
Avila, J;
Schöll, M;
Kovacs, G;
Kövari, E;
Skrabana, R;
Evans, L;
... Zilka, N; + view all
(2019)
A walk through tau therapeutic strategies.
Acta Neuopathologica Communications
10.1186/s40478-019-0664-z.
|
Jansen, IE;
Savage, JE;
Watanabe, K;
Bryois, J;
Williams, DM;
Steinberg, S;
Sealock, J;
... Posthuma, D; + view all
(2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.
Nature Genetics
, 51
pp. 404-413.
10.1038/s41588-018-0311-9.
|
Jaunmuktane, Z;
Brandner, S;
(2019)
On the journey to uncover the causes of selective cellular and regional vulnerability in neurodegeneration.
Acta Neuropathologica
, 138
pp. 677-680.
10.1007/s00401-019-02079-9.
|
Jaunmuktane, Z;
Brandner, S;
(2019)
Transmissible human proteopathies: an expanding field.
Diagnostic Histopathology
, 25
(1)
pp. 16-22.
10.1016/j.mpdhp.2018.11.002.
|
Jaunmuktane, Z;
Capper, D;
Jones, DTW;
Schrimpf, D;
Sill, M;
Dutt, M;
Suraweera, N;
... Brandner, S; + view all
(2019)
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre.
Acta Neuropathologica Communications
, 7
, Article 24. 10.1186/s40478-019-0668-8.
|
Jensen, CS;
Bahl, JM;
Østergaard, LB;
Høgh, P;
Wermuth, L;
Heslegrave, A;
Zetterberg, H;
... Simonsen, AH; + view all
(2019)
Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.
Experimental Gerontology
, 121
pp. 91-98.
10.1016/j.exger.2019.04.003.
|
Jeppsson, A;
Wikkelsö, C;
Blennow, K;
Zetterberg, H;
Constantinescu, R;
Remes, AM;
Herukka, S-K;
... Tullberg, M; + view all
(2019)
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(10)
pp. 1117-1123.
10.1136/jnnp-2019-320826.
|
Joel, Z;
Izquierdo, P;
Salih, DA;
Richardson, JC;
Cummings, DM;
Edwards, FA;
(2019)
Improving Mouse Models for Dementia. Are All the Effects in Tau Mouse Models Due to Overexpression?
Cold Spring Harbor Symposia on Quantitative Biology
, 83
pp. 151-161.
10.1101/sqb.2018.83.037531.
|
Johansson, L;
Sacuiu, S;
Kern, S;
Guo, X;
Zetterberg, H;
Blennow, K;
Zettergren, A;
(2019)
Longstanding psychological stress in relation to biomarkers of neuronal dysfunction in cerebrospinal fluid: a 25-year follow-up study in women.
Neurobiology of Aging
, 80
pp. 111-115.
10.1016/j.neurobiolaging.2019.02.013.
|
Johnson, EB;
Scahill, RI;
Tabrizi, SJ;
(2019)
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images.
Journal of Visualized Experiments
, 143
, Article e58198. 10.3791/58198.
|
Jonaitis, EM;
Koscik, RL;
Clark, LR;
Ma, Y;
Betthauser, TJ;
Berman, SE;
Allison, SL;
... Johnson, SC; + view all
(2019)
Measuring longitudinal cognition: Individual tests versus composites.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 74-84.
10.1016/j.dadm.2018.11.006.
|
Kagiava, A;
Richter, J;
Tryfonos, C;
Karaiskos, C;
Heslegrave, AJ;
Sargiannidou, I;
Rossor, AM;
... Kleopa, KA; + view all
(2019)
Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.
Human Molecular Genetics
, 28
(21)
pp. 3528-3542.
10.1093/hmg/ddz199.
|
Kam, K;
Parekh, A;
Sharma, RA;
Andrade, A;
Lewin, M;
Castillo, B;
Bubu, OM;
... Osorio, RS; + view all
(2019)
Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau.
Molecular Neurodegeneration
, 14
, Article 10. 10.1186/s13024-019-0309-5.
|
Kapoor, M;
Foiani, M;
Heslegrave, A;
Zetterberg, H;
Lunn, MP;
Malaspina, A;
Gillmore, JD;
... Reilly, MM; + view all
(2019)
Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.
Journal of the Peripheral Nervous System
, 24
(4)
pp. 314-319.
10.1111/jns.12350.
|
Katrak, S;
Pauranik, A;
Desai, S;
Mead, S;
Beck, J;
Brandner, S;
Collinge, J;
(2019)
Familial Creutzfeldt-Jakob disease in an Indian kindred.
Annals of Indian Academy of Neurology
, 22
(4)
pp. 458-461.
10.4103/aian.AIAN_214_19.
|
Kehoe, PG;
Al Mulhim, N;
Zetterberg, H;
Blennow, K;
Miners, JS;
(2019)
Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
Journal of Alzheimer’s Disease
, 72
(2)
pp. 525-535.
10.3233/JAD-190721.
|
Keuss, SE;
Bowen, J;
Schott, JM;
(2019)
Looking beyond the eyes: visual impairment in posterior cortical atrophy.
[Editorial comment].
The Lancet
, 394
(10203)
p. 1055.
10.1016/S0140-6736(19)31818-5.
|
Keuss, SE;
Parker, TD;
Lane, CA;
Hoskote, C;
Shah, S;
Cash, DM;
Keshavan, A;
... Schott, JM; + view all
(2019)
Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohort.
BMJ Open
, 9
(7)
, Article e029502. 10.1136/bmjopen-2019-029502.
|
Khoonsari, PE;
Shevchenko, G;
Herman, S;
Remnestål, J;
Giedraitis, V;
Brundin, R;
Gunnarsson, MD;
... Kultima, K; + view all
(2019)
Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.
Journal of Alzheimer's Disease
, 67
(2)
pp. 639-651.
10.3233/JAD-180855.
|
Kim, J;
Lana, B;
Torelli, S;
Ryan, D;
Catapano, F;
Ala, P;
Luft, C;
... Lin, Y-Y; + view all
(2019)
A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.
EMBO Reports
, Article e47967. 10.15252/embr.201947967.
(In press).
|
Kim, M;
Snowden, S;
Suvitaival, T;
Ali, A;
Merkler, DJ;
Ahmad, T;
Westwood, S;
... Legido-Quigley, C; + view all
(2019)
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimer's & Dementia
, 15
(6)
pp. 817-827.
10.1016/j.jalz.2019.03.004.
|
Koriath, C;
Lashley, T;
Taylor, W;
Druyeh, R;
Dimitriadis, A;
Denning, N;
Williams, J;
... Mead, S; + view all
(2019)
ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 277-280.
10.1016/j.dadm.2019.01.010.
|
Kovac, S;
Preza, E;
Houlden, H;
Walker, MC;
Abramov, AY;
(2019)
Impaired Bioenergetics in Mutant Mitochondrial DNA Determines Cell Fate During Seizure-Like Activity.
Molecular Neurobiology
, 56
(1)
pp. 321-334.
10.1007/s12035-018-1078-9.
|
Kranaster, L;
Blennow, K;
Zetterberg, H;
Sartorius, A;
(2019)
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy—A pilot study.
Journal of Affective Disorders
, 253
pp. 449-453.
10.1016/j.jad.2019.04.080.
|
Kun-Rodrigues, C;
Orme, T;
Carmona, S;
Hernandez, DG;
Ross, OA;
Eicher, JD;
Shepherd, C;
... Bras, J; + view all
(2019)
A comprehensive screening of copy number variability in dementia with Lewy bodies.
Neurobiology of Aging
, 75
, Article 223.e1-223.e10. 10.1016/j.neurobiolaging.2018.10.019.
|
Kundu, S;
Lukemire, J;
Wang, Y;
Guo, Y;
Alzheimer’s Disease Neuroimaging Initiative;
(2019)
A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer's Disease Data.
Scientific Reports
, 9
, Article 19589. 10.1038/s41598-019-55818-z.
|
Kunkle, BW;
Grenier-Boley, B;
Sims, R;
Bis, JC;
Damotte, V;
Naj, AC;
Boland, A;
... Pericak-Vance, MA; + view all
(2019)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Nature Genetics
, 51
pp. 414-430.
10.1038/s41588-019-0358-2.
|
Laferrière, F;
Maniecka, Z;
Pérez-Berlanga, M;
Hruska-Plochan, M;
Gilhespy, L;
Hock, E-M;
Wagner, U;
... Polymenidou, M; + view all
(2019)
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
Nature Neuroscience
, 22
(1)
pp. 65-77.
10.1038/s41593-018-0294-y.
|
Lamb, R;
Rohrer, JD;
Real, R;
Lubbe, SJ;
Waite, AJ;
Blake, DJ;
Walters, RJ;
... Morris, HR; + view all
(2019)
A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders.
Cold Spring Harbor Molecular Case Studies
, 5
(3)
, Article a003913. 10.1101/mcs.a003913.
|
Lane, CA;
Barnes, J;
Nicholas, JM;
Sudre, CH;
Cash, DM;
Malone, IB;
Parker, TD;
... Schott, JM; + view all
(2019)
Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.
JAMA Neurology
, 77
(2)
pp. 175-183.
10.1001/jamaneurol.2019.3774.
|
Lane, CA;
Barnes, J;
Nicholas, JM;
Sudre, CH;
Cash, DM;
Parker, TD;
Malone, IB;
... Schott, JM; + view all
(2019)
Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study.
Lancet Neurology
10.1016/S1474-4422(19)30228-5.
(In press).
|
Langbehn, DR;
Stout, JC;
Gregory, S;
Mills, JA;
Durr, A;
Leavitt, BR;
Roos, RAC;
... TRACK-HD and Track-On HD Groups; + view all
(2019)
Association of CAG Repeats With Long-term Progression in Huntington Disease.
JAMA Neurology
10.1001/jamaneurol.2019.2368.
(In press).
|
Law, LL;
Sprecher, KE;
Dougherty, RJ;
Edwards, DF;
Koscik, RL;
Gallagher, CL;
Carlsson, CM;
... Okonkwo, OC; + view all
(2019)
Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort.
Journal of Alzheimer's Disease
, 69
(1)
pp. 111-121.
10.3233/JAD-180291.
|
Leal, IC;
Rodrigues, FB;
Sousa, DC;
Duarte, G;
Romão, VC;
Marques-Neves, C;
Costa, J;
(2019)
Anti-TNF Drugs for Chronic Uveitis in Adults—A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Frontiers in Medicine
, 6
, Article 104. 10.3389/fmed.2019.00104.
|
Leavey, N;
Hammond, SP;
Shepstone, L;
Cross, J;
Zetterberg, H;
Cunningham, C;
MacLullich, A;
... Fox, C; + view all
(2019)
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients.
BMC Neurology
, 19
(1)
, Article 223. 10.1186/s12883-019-1447-7.
|
Lee, G;
Nho, K;
Kang, B;
Sohn, K-A;
Kim, D;
for Alzheimer’s Disease Neuroimaging Initiative;
(2019)
Predicting Alzheimer's disease progression using multi-modal deep learning approach.
Scientific Reports
, 9
, Article 1952. 10.1038/s41598-018-37769-z.
|
Leonenko, G;
Shoai, M;
Bellou, E;
Sims, R;
Williams, J;
Hardy, J;
Escott-Price, V;
(2019)
Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
Annals of Neurology
, 86
(3)
pp. 427-435.
10.1002/ana.25530.
|
Leonenko, G;
Sims, R;
Shoai, M;
Frizzati, A;
Bossu, P;
Spalletta, G;
Fox, NC;
... Munger, R; + view all
(2019)
Polygenic risk and hazard scores for Alzheimer's disease prediction.
Annals of Clinical and Translational Neurology
, 6
(3)
pp. 456-465.
10.1002/acn3.716.
|
Lerche, S;
Wurster, I;
Röben, B;
Machetanz, G;
Zimmermann, M;
Bernhard, F;
Stransky, E;
... Brockmann, K; + view all
(2019)
Parkinson’s disease: evolution of cognitive impairment and CSF Aβ₁−₄₂ profiles in a prospective longitudinal study.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(2)
pp. 165-170.
10.1136/jnnp-2018-318956.
|
Leuzy, A;
Cicognola, C;
Chiotis, K;
Saint-Aubert, L;
Lemoine, L;
Andreasen, N;
Zetterberg, H;
... Nordberg, A; + view all
(2019)
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-018-4242-6.
(In press).
|
Lewis, MA;
Ganeshan, B;
Barnes, A;
Bisdas, S;
Jaunmuktane, Z;
Brandner, S;
Endozo, R;
... Thust, SC; + view all
(2019)
Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping.
European Journal of Radiology
, 113
pp. 116-123.
10.1016/j.ejrad.2019.02.014.
|
Leyland, L-A;
Bremner, FD;
Mahmood, R;
Hewitt, S;
Durteste, M;
Cartlidge, MRE;
Lai, MM-M;
... Weil, RS; + view all
(2019)
Visual tests predict dementia risk in Parkinson's disease.
Neurology: Clinical Practice
10.1212/CPJ.0000000000000719.
(In press).
|
Leyland, L-A;
Spencer, B;
Beale, N;
Jones, T;
van Reekum, CM;
(2019)
The effect of cycling on cognitive function and well-being in older adults.
PLOS ONE
, 14
(2)
, Article e0211779. 10.1371/journal.pone.0211779.
|
Lleó, A;
Alcolea, D;
Martínez-Lage, P;
Scheltens, P;
Parnetti, L;
Poirier, J;
Simonsen, AH;
... Blennow, K; + view all
(2019)
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
Alzheimer's & Dementia
, 15
(6)
pp. 742-753.
10.1016/j.jalz.2019.01.015.
|
Llibre-Guerra, JJ;
Li, Y;
Schindler, SE;
Gordon, BA;
Fagan, AM;
Morris, JC;
Benzinger, TLS;
... McDade, E; + view all
(2019)
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease.
JAMA Network Open
, 2
(12)
, Article e1917126. 10.1001/jamanetworkopen.2019.17126.
|
Lombardi, V;
Bombaci, A;
Zampedri, L;
Lu, C-H;
Malik, B;
Zetterberg, H;
Heslegrave, AJ;
... Fratta, P; + view all
(2019)
Plasma pNfH levels differentiate SBMA from ALS.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320624.
(In press).
|
Lombardi, V;
Querin, G;
Ziff, OJ;
Zampedri, L;
Martinelli, I;
Heller, C;
Foiani, M;
... Fratta, P; + view all
(2019)
Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
Neurology
, 92
(11)
10.1212/WNL.0000000000007097.
(In press).
|
Lopez-Font, I;
Boix, CP;
Zetterberg, H;
Blennow, K;
Sáez-Valero, J;
(2019)
Characterization of Cerebrospinal Fluid BACE1 Species.
Molecular Neurobiology
, 56
pp. 8603-8616.
10.1007/s12035-019-01677-8.
|
Lopez-Font, I;
Sogorb-Esteve, A;
Javier-Torrent, M;
Brinkmalm, G;
Herrando-Grabulosa, M;
García-Lareu, B;
Turon-Sans, J;
... Sáez-Valero, J; + view all
(2019)
Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Neurobiology of Disease
, 124
pp. 428-438.
10.1016/j.nbd.2018.12.021.
|
Lowe, AJ;
Paquola, C;
Vos de Wael, R;
Girn, M;
Lariviere, S;
Tavakol, S;
Caldairou, B;
... Bernhardt, BC; + view all
(2019)
Targeting age‐related differences in brain and cognition with multimodal imaging and connectome topography profiling.
Human Brain Mapping
, 40
(18)
pp. 5213-5230.
10.1002/hbm.24767.
|
Lu, K;
Nicholas, JM;
Collins, JD;
James, S-N;
Parker, TD;
Lane, CA;
Keshavan, A;
... Schott, JM; + view all
(2019)
Cognition at age 70: Life course predictors and associations with brain pathologies.
Neurology
, 93
10.1212/WNL.0000000000008534.
|
Lu, M;
Banetta, L;
Young, LJ;
Smith, EJ;
Bates, GP;
Zaccone, A;
Schierle, GSK;
... Kaminski, CF; + view all
(2019)
Live-cell super-resolution microscopy reveals a primary role for diffusion in polyglutamine-driven aggresome assembly.
Journal of Biological Chemistry
, 294
(1)
pp. 257-268.
10.1074/jbc.RA118.003500.
|
Lynch, DS;
Wade, C;
Paiva, ARBD;
John, N;
Kinsella, JA;
Merwick, Á;
Ahmed, RM;
... Chataway, J; + view all
(2019)
Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(5)
pp. 543-554.
10.1136/jnnp-2018-319481.
|
Ma, Y;
Jun, GR;
Chung, J;
Zhang, X;
Kunkle, BW;
Naj, AC;
White, CC;
... Yu, L; + view all
(2019)
CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.
Aging Cell
, 18
(4)
, Article e12964. 10.1111/acel.12964.
|
MacGregor Sharp, M;
Bulters, D;
Brandner, S;
Holton, J;
Verma, A;
Werring, DJ;
Carare, RO;
(2019)
The fine anatomy of the perivascular compartment in the human brain: relevance to dilated perivascular spaces in cerebral amyloid angiopathy.
Neuropathology and Applied Neurobiology
, 45
(3)
pp. 305-308.
10.1111/nan.12480.
|
Magno, L;
Lessard, CB;
Martins, M;
Lang, V;
Cruz, P;
Asi, Y;
Katan, M;
... Whiting, PJ; + view all
(2019)
Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
Alzheimer's Research & Therapy
, 11
, Article 16. 10.1186/s13195-019-0469-0.
|
Malek, N;
Kanavou, S;
Lawton, MA;
Pitz, V;
Grosset, KA;
Bajaj, N;
Barker, RA;
... PRoBaND clinical consortium; + view all
(2019)
L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.
Parkinsonism & Related Disorders
, 65
pp. 55-61.
10.1016/j.parkreldis.2019.05.022.
|
Marinescu, RV;
Eshaghi, A;
Lorenzi, M;
Young, AL;
Oxtoby, NP;
Garbarino, S;
Crutch, SJ;
... Alzheimer's Disease Neuroimaging Initiative, .; + view all
(2019)
DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders.
NeuroImage
, 192
pp. 166-177.
10.1016/j.neuroimage.2019.02.053.
|
Marini, S;
Crawford, K;
Morotti, A;
Lee, MJ;
Pezzini, A;
Moomaw, CJ;
Flaherty, ML;
... Sheth, K; + view all
(2019)
Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.
JAMA Neurology
, 76
(4)
pp. 480-491.
10.1001/jamaneurol.2018.4519.
|